Selective Internal Radiation Therapy (SIRT) Using SIR-Spheres ® Y-90 Resin Microspheres on DoR & ORR in Unresectable Hepatocellular Carcinoma Patients
Conditions: Unresectable Hepatocellular Carcinoma; BCLC Stage A Hepatocellular Carcinoma; BCLC Stage B Hepatocellular Carcinoma Intervention: Device: Resin microspheres containing yttrium-90 (Y-90) Sponsors: Sirtex Medical; Bright Research Partners Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Brachytherapy | Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Liver Cancer | Radiation Therapy | Research